QA: Anixa Biosciences Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000715446_2021_Anixa_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0000715446, Anixa Biosciences Inc

  xvar xval
0 AssetsCurrent 9,368,624
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 84,340
4 LiabilitiesCurrent 1,188,591
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,610,521
9 ResearchAndDevelopmentExpense 4,382,251
10 remainder_Expenses 144,932
11 remainder_Revenues -17,958
12 remainder_NetIncome 46,814
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 9,452,964
1 Liabilities 1,188,591
2 Expenses 10,137,704
3 Revenues -17,958
4 StockholdersEquity 8,264,373
5 NetIncome -10,108,848
6 ComprehensiveNetIncome -10,108,848
7 BaseVar 10,422,016
8 EconomicCapitalRatiobeforeLimitedLiability 1.49
9 EconomicCapitalRatio 2.67

Edgar->Model Mapping

Feature Distribution

Change over Time